Worldwide, tuberculosis (TB) remains the leading cause of morbidity and mortality for patients living with HIV (PLWH). As of 2009, the World Health Organization (WHO) recommended daily antituberculosis therapy (ATT) for TB in PLWH, while the standard of care in India at the time was intermittent, or thrice-weekly, ATT in those patients.
